Risk-based fraud detection: How centralized monitoring can boost data quality
Authors: Sylviane de Viron, Laura Trotta, Sebastiaan Höppner, Steve Young, Marc Buyse A new study has shown how risk-based monitoring can help detect site fraud…
Read More
HiRO and CluePoints Partnership Offers Market-Leading RBQM Opportunities in China
King of Prussia, PA, December 13, 2021: Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research Organization (CRO), has collaborated with CluePoints, the premier provider…
Read More
CluePoints Wins Scrip Award for Clinical Advance of the Year 2021
Company wins prestigious accolade for its collaboration with BioNTech and Pfizer in the Phase I/II/III study of SARS-COV-2 RNA vaccine BNT162b2 (Comirnaty)CluePoints, the premier provider…
Read More
CluePoints SVP of Business Development to Speak at Clinical Trials Europe
John Hall, SVP Business Development at CluePoints will share insights into the dimensions of risk associated with Decentralized Clinical Trials (DCTs) at Clinical Trials Europe.…
Read More
CluePoints Chief Scientific Officer to Speak at CNS Summit Next Month
Steve Young, Chief Scientific Officer at CluePoints, will take to the podium at this year’s CNS Summit with Lynne Cesario, Global Risk-Based Monitoring Program Lead…
Read More
CluePoints Shortlisted for Multiple Awards in Recognition of Pioneering Risk-Based Quality Management Solution
King of Prussia, PA – October 26, 2021: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has been…
Read More
CluePoints Chief Scientific Officer and Pfizer’s Global RBM Program Lead to Speak at #CQOF2021
Join us at #CQOF2021! As well as hosting a booth at the Clinical Quality Oversight Forum where visitors will be able to learn about our…
Read More
Will ICH E6 (R3) Unleash the Potential of Risk-Based Trials?
Researchers have been slow to fully adopt innovations designed to overcome the challenges to modern day clinical research, in no small part due to a…
Read More
CluePoints Partners with ZS to Provide Best-in-Class RBQM Expertise and Technology, Increasing Clinical Trial Efficiency and Improving Patient Outcomes
August 25, 2021: CluePoints, the premier provider of Risk-Based Quality Management software for clinical trials, has partnered with ZS, a global professional services firm with technology and…
Read More
Events
Find out where we’re headed next.
Featured Whitepaper
ICH E6 (R2)
Summary
Paper
Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.
Featured Webinar
ICH E6 (R2)
Webinar
Series
This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.
We're Kind of a Big Deal.
3,400
Platform Users
700
Studies De-Risked
64,000
Issues Detected
